{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:16:40Z","timestamp":1769149000708,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.drugalcdep.2014.02.016","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T08:32:32Z","timestamp":1394094752000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome"],"prefix":"10.1016","volume":"138","author":[{"given":"Adam. M.","family":"Leventhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Bergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary E.","family":"Swan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel F.","family":"Tyndale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caryn","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David V.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0005","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/jnci\/djq232","article-title":"Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study","volume":"102","author":"Amos","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0010","series-title":"Annual Meeting for the American Society of Human Genetics","article-title":"Genetic associations with response variability on the continuous performance task in AD\/HD families","author":"Ashley-Koch","year":"2006"},{"issue":"Suppl. 4","key":"10.1016\/j.drugalcdep.2014.02.016_bib0015","first-page":"S555","article-title":"Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence","volume":"9","author":"Baker","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0020","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1038\/npp.2009.52","article-title":"Dopamine genes and nicotine dependence in treatment-seeking and community smokers","volume":"34","author":"Bergen","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/FPC.0b013e32835cdabd","article-title":"Nicotinic acetylcholine receptor variation and response to smoking cessation therapies","volume":"23","author":"Bergen","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0030","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/ntr\/nts245","article-title":"The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence","volume":"15","author":"Bergen","year":"2013","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10571-009-9448-5","article-title":"Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India","volume":"30","author":"Bhaduri","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ntr\/ntp030","article-title":"The Wisconsin predicting patients\u2019 relapse questionnaire","volume":"11","author":"Bolt","year":"2009","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0045","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2105\/AJPH.90.7.1122","article-title":"Predicting smoking cessation and major depression in nicotine-dependent smokers","volume":"90","author":"Breslau","year":"2000","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2007.06.043","article-title":"The neurobiology and genetics of impulse control disorders: relationships to drug addictions","volume":"75","author":"Brewer","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0055","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.neubiorev.2012.02.015","article-title":"Tobacco addiction and the dysregulation of brain stress systems","volume":"36","author":"Bruijnzeel","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4161\/cbt.10.1.11949","article-title":"Novel somatic mutations in heterotrimeric G proteins in melanoma","volume":"10","author":"Cardenas-Navia","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1176\/appi.ajp.2012.11101545","article-title":"Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success","volume":"169","author":"Chen","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0070","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1086\/522036","article-title":"So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests","volume":"81","author":"Conneely","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0075","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/hmg\/ddn181","article-title":"Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation","volume":"17","author":"Conti","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-004-1840-8","article-title":"Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology","volume":"174","author":"Cubells","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0085","first-page":"4","article-title":"Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments","volume":"6","author":"D'Souza","year":"2011","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/14622200701382033","article-title":"Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation","volume":"9","author":"David","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.tpj.6500447","article-title":"Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch","volume":"8","author":"David","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0100","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14622200701705027","article-title":"Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials","volume":"9","author":"David","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0105","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2217\/pgs.10.75","article-title":"Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients","volume":"11","author":"De Ruyck","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0110","first-page":"921","article-title":"Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population","volume":"12","author":"Excoffier","year":"1995","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0115","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/ntr\/nts018","article-title":"The Fagerstrom Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data","volume":"14","author":"Fagerstrom","year":"2012","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0120","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/ntr\/ntr012","article-title":"Association of the nicotine metabolite ratio and CHRNA5\/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers","volume":"13","author":"Falcone","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0125","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular genetics of attention-deficit\/hyperactivity disorder","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0130","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1162\/jocn.2008.21164","article-title":"Both a nicotinic single nucleotide polymorphism (SNP) and a noradrenergic SNP modulate working memory performance when attention is manipulated","volume":"21","author":"Greenwood","year":"2009","journal-title":"J. Cogn. Neurosci."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0135","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archgenpsychiatry.2012.124","article-title":"Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers","volume":"69","author":"Hartz","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0140","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0145","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1360-0443.2003.00381.x","article-title":"Probabilities of alcohol high-risk drinking, abuse or dependence estimated on grounds of tobacco smoking and nicotine dependence","volume":"98","author":"John","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0150","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btn564","article-title":"SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap","volume":"24","author":"Johnson","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0155","first-page":"88","article-title":"Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies","volume":"34","author":"Kebir","year":"2009","journal-title":"J. Psychiatr. Neurosci."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/npp.2011.232","article-title":"Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials","volume":"37","author":"King","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0165","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.biopsych.2006.10.005","article-title":"CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial","volume":"62","author":"Lee","year":"2007","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.npp.1300861","article-title":"Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials","volume":"31","author":"Lerman","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0175","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/0003-4819-140-6-200403160-00009","article-title":"Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial","volume":"140","author":"Lerman","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(02)00067-4","article-title":"Mediating mechanisms for the impact of bupropion in smoking cessation treatment","volume":"67","author":"Lerman","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0185","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1037\/0278-6133.22.5.541","article-title":"Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial","volume":"22","author":"Lerman","year":"2003","journal-title":"Health Psychol."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0190","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.clpt.2006.02.006","article-title":"Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation","volume":"79","author":"Lerman","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1369-1600.2012.00435.x","article-title":"Functional neuroimaging study in identical twin pairs discordant for regular cigarette smoking","volume":"18","author":"Lessov-Schlaggar","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0200","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/tpj.2010.64","article-title":"Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation","volume":"12","author":"Leventhal","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0205","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1158\/1055-9965.EPI-05-0723","article-title":"CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking","volume":"15","author":"Malaiyandi","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0210","series-title":"Psychopharmacology: Drugs, the Brain and Behavior","author":"Meyer","year":"2004"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0215","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ntr\/nts174","article-title":"Lack of association of OPRM1 genotype and smoking cessation","volume":"15","author":"Munafo","year":"2013","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0220","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ntr\/ntr106","article-title":"CHRNA3 rs1051730 genotype and short-term smoking cessation","volume":"13","author":"Munafo","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0225","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.0956-7976.2005.00804.x","article-title":"Beyond heritability: neurotransmitter genes differentially modulate visuospatial attention and working memory","volume":"16","author":"Parasuraman","year":"2005","journal-title":"Psychol. Sci."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0230","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/1462220031000094178","article-title":"Nicotine dependence and treatment outcome among African American cocaine-dependent patients","volume":"5","author":"Patkar","year":"2003","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0235","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/clpt.2008.57","article-title":"Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion","volume":"84","author":"Patterson","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1037\/0022-006X.72.2.139","article-title":"A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68)","volume":"72","author":"Piper","year":"2004","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0306-4603(94)90049-3","article-title":"Reliability of the fagerstrom tolerance questionnaire and the fagerstrom test for nicotine dependence","volume":"19","author":"Pomerleau","year":"1994","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0250","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/genetics\/155.2.945","article-title":"Inference of population structure using multilocus genotype data","volume":"155","author":"Pritchard","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0290","series-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2008"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0255","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/npp.2010.7","article-title":"Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence","volume":"35","author":"Ray","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2119\/molmed.2009.00159","article-title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score","volume":"16","author":"Rose","year":"2010","journal-title":"Mol. Med."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajmg.b.31155","article-title":"Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy","volume":"156B","author":"Sarginson","year":"2011","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0270","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/338688","article-title":"Score tests for association between traits and haplotypes when linkage phase is ambiguous","volume":"70","author":"Schaid","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0275","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thoraxjnl-2011-200154","article-title":"Genome-wide association study of smoking behaviours in patients with COPD","volume":"66","author":"Siedlinski","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0280","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000265131","article-title":"Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians","volume":"61","author":"Srivastava","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0285","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/14622200701239605","article-title":"An association of CYP2A6 genotype and smoking topography","volume":"9","author":"Strasser","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0295","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ng.573","article-title":"Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior","volume":"42","author":"Thorgeirsson","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0300","doi-asserted-by":"crossref","unstructured":"Tobacco and Genetics Consortium, 2010. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42, 441\u2013447.","DOI":"10.1038\/ng.571"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0305","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archpsyc.65.6.683","article-title":"Molecular genetics of successful smoking cessation: convergent genome-wide association study results","volume":"65","author":"Uhl","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0310","unstructured":"USDHHS, 2008. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. U.S. Public Health Service, Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0315","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/jnci\/djr237","article-title":"Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk","volume":"103","author":"Wassenaar","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0592-85","article-title":"Evolution of the mammalian G protein alpha subunit multigene family","volume":"1","author":"Wilkie","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0325","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1124\/dmd.105.006254","article-title":"CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions","volume":"33","author":"Yamanaka","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.drugalcdep.2014.02.016_bib0330","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/318198","article-title":"A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus","volume":"68","author":"Zabetian","year":"2001","journal-title":"Am. J. Hum. Genet."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:20:08Z","timestamp":1746145208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":66,"alternative-id":["S0376871614000714"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.02.016","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}